Last month, the FDA approved the use of ALung Technologies' Hemolung Respiratory Assist System, which received the CE mark in 2013.
ALung said that it has been researching Hemolung's respiratory assist system for nearly 10 years. The auxiliary device can provide patients with a kind of respiratory dialysis help, which is to take away carbon dioxide through the blood and transport it back to oxygen. This equipment can help respiratory distress. The patient relieves the burden on the lungs while helping to treat the disease.
Today, multiple research groups from the National Institute for Health Research (NIHR) and the National Health Service (NHS) have conducted a Hemolung facility for 1,120 patients in 40 hospitals. Research, for the study of patients with respiratory failure. This test is by far the largest low-flow in vitro CO2 removal test using Hemolung.
Alung CEO Peter DeComo said in a statement that widespread carbon dioxide removal in vitro can support this study. Unlike other technologies, Hemolung breathing assistance systems provide efficient support in a minimally invasive manner, while safety And simplicity ensures that it can be used in routine ICU treatment. NIHR has invested $3.2 million to support the research and is scheduled to begin in March 2016. As early as February, Alung has introduced a new generation of the device that can remove 30% to 50%. The carbon dioxide produced by the body's metabolism, this device's carbon dioxide removal is twice as much as other technologies.
Reducing ventilator pressure is an important intervention to improve patient breathing, and the use of a pulmonary protective ventilation strategy can lead to the accumulation of carbon dioxide in the patient's blood; the researchers point out that carbon dioxide can be removed through the blood, and this It does not rely on degenerating lung tissue with extracorporeal devices, which is very similar to kidney dialysis; through multiple studies, researchers believe that Hemolung breathing assistance systems can be used as a safer and more effective way to meet clinical patients. Demand.
Nicotine Mints,Nicotine Breath Mints,Nicotine Fresh Mints,Nicotine Probiotic Mints
Soar Biotech Co.,Ltd , https://www.xylitgum.com